vs
Profound Medical Corp.（PROF）与维珍银河（SPCE）财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是维珍银河的1.4倍（$6.0M vs $4.2M），Profound Medical Corp.净利率更高（-136.8% vs -2222.2%，领先2085.4%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
维珍银河控股是英美合资的太空飞行公司，由理查德·布兰森创立，维珍集团通过维珍投资有限公司持有该公司11.9%的股份，公司核心业务围绕商业载人太空旅行展开，是全球商业太空探索领域的先行者。
PROF vs SPCE — 直观对比
营收规模更大
PROF
是对方的1.4倍
$4.2M
净利率更高
PROF
高出2085.4%
-2222.2%
损益表 — Q4 FY2025 vs Q2 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $4.2M |
| 净利润 | $-8.2M | $-93.8M |
| 毛利率 | 66.8% | -546.6% |
| 营业利润率 | -123.3% | -2412.1% |
| 净利率 | -136.8% | -2222.2% |
| 营收同比 | — | 125.5% |
| 净利润同比 | — | 30.2% |
| 每股收益（稀释后） | $0.27 | $-4.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFSPCE
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $2.3M | — | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.0M | ||
| Q4 23 | — | $2.8M | ||
| Q3 23 | — | $1.7M |
净利润PROFSPCE
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-8.0M | — | ||
| Q2 25 | $-15.7M | — | ||
| Q1 25 | $-10.7M | — | ||
| Q2 24 | — | $-93.8M | ||
| Q1 24 | — | $-102.0M | ||
| Q4 23 | — | $-104.0M | ||
| Q3 23 | — | $-104.6M |
毛利率PROFSPCE
| Q4 25 | 66.8% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 81.7% | — | ||
| Q1 25 | 79.2% | — | ||
| Q2 24 | — | -546.6% | ||
| Q1 24 | — | -1038.1% | ||
| Q4 23 | — | -766.4% | ||
| Q3 23 | — | -1384.3% |
营业利润率PROFSPCE
| Q4 25 | -123.3% | — | ||
| Q3 25 | -176.2% | — | ||
| Q2 25 | -696.9% | — | ||
| Q1 25 | -477.0% | — | ||
| Q2 24 | — | -2412.1% | ||
| Q1 24 | — | -5599.9% | ||
| Q4 23 | — | -4067.8% | ||
| Q3 23 | — | -6613.0% |
净利率PROFSPCE
| Q4 25 | -136.8% | — | ||
| Q3 25 | -157.7% | — | ||
| Q2 25 | -792.3% | — | ||
| Q1 25 | -458.1% | — | ||
| Q2 24 | — | -2222.2% | ||
| Q1 24 | — | -5139.1% | ||
| Q4 23 | — | -3701.8% | ||
| Q3 23 | — | -6053.5% |
每股收益（稀释后）PROFSPCE
| Q4 25 | $0.27 | — | ||
| Q3 25 | $0.26 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.36 | — | ||
| Q2 24 | — | $-4.36 | ||
| Q1 24 | — | $-5.10 | ||
| Q4 23 | — | $-14.49 | ||
| Q3 23 | — | $-5.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $775.7M |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $394.8M |
| 总资产 | $77.5M | $1.1B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资PROFSPCE
| Q4 25 | $59.7M | — | ||
| Q3 25 | $24.8M | — | ||
| Q2 25 | $35.2M | — | ||
| Q1 25 | $46.4M | — | ||
| Q2 24 | — | $775.7M | ||
| Q1 24 | — | $765.2M | ||
| Q4 23 | — | $874.0M | ||
| Q3 23 | — | $997.1M |
总债务PROFSPCE
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
股东权益PROFSPCE
| Q4 25 | $66.4M | — | ||
| Q3 25 | $32.1M | — | ||
| Q2 25 | $39.3M | — | ||
| Q1 25 | $50.8M | — | ||
| Q2 24 | — | $394.8M | ||
| Q1 24 | — | $417.6M | ||
| Q4 23 | — | $505.5M | ||
| Q3 23 | — | $599.4M |
总资产PROFSPCE
| Q4 25 | $77.5M | — | ||
| Q3 25 | $42.3M | — | ||
| Q2 25 | $49.7M | — | ||
| Q1 25 | $60.9M | — | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B | ||
| Q4 23 | — | $1.2B | ||
| Q3 23 | — | $1.3B |
负债/权益比PROFSPCE
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-79.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-113.5M |
| 自由现金流率自由现金流/营收 | — | -2690.7% |
| 资本支出强度资本支出/营收 | — | 815.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-458.3M |
8季度趋势，按日历期对齐
经营现金流PROFSPCE
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-9.6M | — | ||
| Q2 25 | $-13.7M | — | ||
| Q1 25 | $-8.3M | — | ||
| Q2 24 | — | $-79.1M | ||
| Q1 24 | — | $-113.2M | ||
| Q4 23 | — | $-95.3M | ||
| Q3 23 | — | $-91.5M |
自由现金流PROFSPCE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $-113.5M | ||
| Q1 24 | — | $-126.3M | ||
| Q4 23 | — | $-113.7M | ||
| Q3 23 | — | $-104.8M |
自由现金流率PROFSPCE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | -2690.7% | ||
| Q1 24 | — | -6362.8% | ||
| Q4 23 | — | -4046.9% | ||
| Q3 23 | — | -6066.1% |
资本支出强度PROFSPCE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 815.5% | ||
| Q1 24 | — | 658.5% | ||
| Q4 23 | — | 653.9% | ||
| Q3 23 | — | 771.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
